反应详情

A solution of di-tert-butyl 2,2′-((2-(2-((((1-(2-((3-iodophenyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)(4-sulfamoylphenethyl)amino)methyl)-1H-imidazo 1-yl)acetyl)azanediyl)diacetate (45 mg, 0.0497 mmol) in DCM (1.0 mL) and TFA (1.0 mL) was stirred at room temperature for 5 hrs. Solvent was removed under a stream of nitrogen to give a residue, which was purified by HPLC to give compound (18) as a white solid (29 mg, 74%). 1H NMR (400 MHz, DMSO-d6) 10.69 (s, 0.66H), 10.61 (s, 0.34; H), 8.10 (s, 0.66; H), 8.07 (s, 0.34; H), 7.69-7.62 (m, 3H), 7.54 (s, 1H), 7.48-7.44 (m, 2H), 7.27 (s, 2H), 7.30-7.26 (m, 3H), 7.13 (t, J=8.0 Hz, 1H), 5.31 (s, 1.32; H), 5.15 (s, 1.32; H), 5.12 (s, 0.68; H), 4.75 (s, 0.68; H), 4.33 (s, 2H), 4.16 (s, 2H), 4.05 (s, 4H), 2.72-2.68 (m, 4H); MS (ESI), 793.1 (M+H)−.

1. customSolvent was removed under a stream of nitrogen
2. customto give a residue, which
3. customwas purified by HPLC